Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
10/24/2002 | US20020155122 Immunologically significant herpes simplex virus antigens and methods for identifying and using same |
10/24/2002 | US20020155121 Virus coat protein/receptor chimeras and methods of use |
10/24/2002 | US20020155115 Cancer therapy |
10/24/2002 | US20020155111 For the vaccination of patients having malignant B cell diseases |
10/24/2002 | US20020155100 Compositions and methods for regulated protein expression in gut |
10/24/2002 | US20020155096 Mixing stem cell preparation with a physiologically acceptable matrix material to form a stem cell matrix; incubating the stem-cell matrix in vitro prior to use in tissue or organ treatment or repair |
10/24/2002 | DE10119905A1 Enriching intermediates in the mevalonate-independent pathway of isoprenoid synthesis, useful for therapeutic activation of T cells, comprises altering enzymatic activity in the pathway |
10/24/2002 | CA2447683A1 Dense/porous structures for use as bone substitutes |
10/24/2002 | CA2445990A1 Full-length human cdnas encoding potentially secreted proteins |
10/24/2002 | CA2444632A1 Vascular endothelial growth factor 2 |
10/24/2002 | CA2444624A1 Vascular endothelial growth factor 2 |
10/24/2002 | CA2444482A1 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells |
10/24/2002 | CA2444264A1 Prodrugs via acylation with cinnamate |
10/24/2002 | CA2444164A1 Pufa polyketide synthase systems and uses thereof |
10/24/2002 | CA2444133A1 Novel streptococcus pneumoniae open reading frames encoding polypeptide antigens and uses thereof |
10/24/2002 | CA2444047A1 Methods to inhibit viral replication |
10/24/2002 | CA2444026A1 Mutants of desoxycytidine kinase having extended enzymatic activity |
10/24/2002 | CA2444004A1 Method for autologous transplantation |
10/24/2002 | CA2443995A1 Endothelial cell expression patterns |
10/24/2002 | CA2443993A1 Methods and reagents for cell transplantation |
10/24/2002 | CA2443984A1 Encapsulated cell indicator system |
10/24/2002 | CA2443968A1 Diagnosis and treatment of cancer: i |
10/24/2002 | CA2443903A1 Antibodies to vla-1 |
10/24/2002 | CA2443897A1 Transporters and ion channels |
10/24/2002 | CA2443874A1 Intermediates and enzymes of the non-mevalonate isoprenoid pathway |
10/24/2002 | CA2443705A1 Cyclic single strand trispecific antibody |
10/24/2002 | CA2443525A1 Human cellular protein gastrointestinal glutathione peroxidase as target for medical intervention against hepatitis c virus infections |
10/24/2002 | CA2443493A1 Surface proteins of streptococcus pyogenes |
10/24/2002 | CA2443408A1 Kinases and phosphatases |
10/24/2002 | CA2443244A1 Enzymes |
10/24/2002 | CA2443147A1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer |
10/24/2002 | CA2443141A1 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer |
10/24/2002 | CA2443123A1 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers |
10/24/2002 | CA2443088A1 Nucleic acid and corresponding protein entitled 121p2a3 useful in treatment and detection of cancer |
10/24/2002 | CA2442819A1 Elimination of endogenous porcine retrovirus |
10/24/2002 | CA2442729A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
10/24/2002 | CA2441699A1 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
10/24/2002 | CA2440846A1 Protein cluster v |
10/24/2002 | CA2438107A1 G-protein coupled receptor molecules and uses thereof |
10/23/2002 | EP1251181A1 Non-recombinant cell lines capable of expressing predominantly cyclic nucleotide phosphodiesterase 4 (PDE4) subtype B and their use for the screening of PDE4 subtype-specific modulators |
10/23/2002 | EP1251177A2 Cytokine-, stress-, and oncoprotein-activited human protein kinase kinases |
10/23/2002 | EP1251176A2 Expression systems utilizing autolyzing fusion proteins and a reducing polypeptide |
10/23/2002 | EP1251170A2 Method and reagent for treatment of NF-kappaB dependent animal diseases |
10/23/2002 | EP1251166A1 Method for selecting spermatozoon |
10/23/2002 | EP1251139A2 Human mindin-like protein and nucleic acids encoding it |
10/23/2002 | EP1250599A2 System for the internal qualitative and quantitative validation of marker indices |
10/23/2002 | EP1250597A2 Identification of peripheral benzodiazepine receptor binding agents |
10/23/2002 | EP1250594A1 Swine defective for transmission of porcine endogenous retrovirus and uses thereof |
10/23/2002 | EP1250455A1 Antisense inhibition of ptp1b expression |
10/23/2002 | EP1250453A1 Use of multiple recombination sites with unique specificity in recombinational cloning |
10/23/2002 | EP1250447A2 Methods, media and apparatus for the introduction of molecules into plant cells and bacteria using aerosol beams |
10/23/2002 | EP1250444A1 Methods for producing a polypeptide using a consensus translational initiator sequence |
10/23/2002 | EP1250443A2 ANTI-CD3 SINGLE-CHAIN ANTIBODIES HAVING HUMAN C $g(m)?3 AND C $g(m)?4 DOMAINS |
10/23/2002 | EP1250434A2 84p2a9: a prostate and testis specific protein highly expressed in prostate cancer |
10/23/2002 | EP1250432A2 Nuclear hormone receptors |
10/23/2002 | EP1250429A2 Human sperm specific lysozyme-like proteins |
10/23/2002 | EP1250425A2 Secreted human proteins, polynucleotides encoding them and methods of using the same |
10/23/2002 | EP1250421A1 Recombinant flaviviruses and methods of use thereof |
10/23/2002 | EP1250420A2 Techniques for growth and differentiation of human pluripotent stem cells |
10/23/2002 | EP1250416A2 Three-dimensional matrix body, and device and method for measuring contractions of a cell tissue |
10/23/2002 | EP1250352A1 Receptor-like protein kinases from nicotiana tabacum |
10/23/2002 | EP1250349A2 Cardiac-cell specific enhancer elements and uses thereof |
10/23/2002 | EP1250154A2 G-csf conjugates |
10/23/2002 | EP1250109A1 Tissue graft |
10/23/2002 | EP1250055A1 Immune modulation with death receptor-induced apoptosis |
10/23/2002 | EP1250041A2 Storage of cells, tissues and organs in gel-based media |
10/23/2002 | EP1250039A1 Transgenic goat producing milk containing human granulocyte-colony stimulating factor |
10/23/2002 | EP1063891A4 Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby |
10/23/2002 | EP1056336A4 Selection of mature sperm by surface membrane determinants |
10/23/2002 | EP0948255A4 Improved chondrogenic differentiation of human mesenchymal stem cells |
10/23/2002 | EP0909278A4 Nephropathy-related immunoglobulin g and antibodies for same |
10/23/2002 | EP0883681B1 Conjugated linoleic acids for attenuating the allergic response |
10/23/2002 | EP0880594B1 Retroviral vector and its use in gene therapy |
10/23/2002 | EP0842262B1 Reversible membrane insert for growing tissue cultures |
10/23/2002 | EP0766745B1 Monoclonal antibody specific for human 4-1bb and cell line producing same |
10/23/2002 | EP0576623B1 Binding domains in notch and delta proteins |
10/23/2002 | CN1376204A Flex seed specific promoters |
10/23/2002 | CN1376201A Immunologically significant herpes simplex virus antigens |
10/23/2002 | CN1376198A Polynucleotide sequences and their use in a method of producing plants with an increased number of stomata |
10/23/2002 | CN1376196A Method for generating immune-compatible cells and tissues using nuclear transfer techniques |
10/23/2002 | CN1376163A Highly purified cytokine activating factor and methods of use |
10/23/2002 | CN1376162A Novel techykinin peptides, precursor peptides thereof and genes encoding the same |
10/23/2002 | CN1376073A Method of expressing antigen on the surface of an antigen-presenting cell by photochemical internalisation |
10/23/2002 | CN1376067A Conditioned cell culture medium compositions and method of use |
10/23/2002 | CN1375554A Method of obtaining mammary gland epithelial cell from mammary gland tissue of mammal |
10/23/2002 | CN1375500A Thymic peptide fusion protein as one new interferon and its prepn. and use |
10/23/2002 | CN1375190A One-step method for producing micro-budlet through tee leaves |
10/22/2002 | US6469231 Starch branching enzyme II of potato |
10/22/2002 | US6469230 Starch debranching enzymes |
10/22/2002 | US6469155 HIgR and related domain which binds glycoprotein D of herpes simplex virus |
10/22/2002 | US6469144 Apo-2li (apo-2 ligand inhibitor, related to apoptosis) monoclonal antibodies |
10/22/2002 | US6469142 Components of nmda receptors that have cation-selective channels and bind glutamate and nmda (n-methyl-d-aspartate) |
10/22/2002 | US6469140 Molecules of the card-related protein family and uses thereof |
10/22/2002 | US6468985 Administering nucleic acid molecule encoding retinoblastoma protein-interacting zinc finger protein at or adjacent to site of tumor, wherein protein comprises specified amino acid sequence and is expressed in tumor cell and reduces its growth |
10/22/2002 | US6468798 Liposome-nucleic acid complexes are prepared then delivered via aerosol to the lung airway; for transforming pulmonary cells and treating lung diseases |
10/22/2002 | US6468794 Enriched central nervous system stem cell and progenitor cell populations, and methods for identifying, isolating and enriching for such populations |
10/22/2002 | US6468791 Chromosone 1 gene and gene products related to Alzheimer's disease |
10/22/2002 | US6468790 Metastatic breast and colon cancer regulated genes |
10/22/2002 | US6468777 Through enhanced control and stabilization of protein production via stress proteins and the resultant protein products |
10/22/2002 | US6468775 From a thermophilic eubacterium; polymerase shows magnesium ion dependent reverse transcriptase activity and 3'-5' exonuclease activity |